Loading...
Planet 13 Holdings Inc.
PLNH•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.23
$0.04(18.62%)
Planet 13 Holdings Inc. (PLNH) Financial Performance & Income Statement Overview
Review Planet 13 Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
18.18%
↑ 18.18%
Operating Income Growth
41.87%
↑ 41.87%
Net Income Growth
38.18%
↑ 38.18%
Operating Cash Flow Growth
142.48%
↑ 142.48%
Operating Margin
-31.64%
↓ 31.64%
Gross Margin
47.41%
↑ 47.41%
Net Profit Margin
-35.56%
↓ 35.56%
ROE
-32.49%
↓ 32.49%
ROIC
-21.55%
↓ 21.55%
Planet 13 Holdings Inc. (PLNH) Income Statement & Financial Overview
Review Planet 13 Holdings Inc.'s (PLNH) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $28.03M | $30.28M | $32.16M | $31.09M |
| Cost of Revenue | $16.02M | $17.19M | $15.46M | $15.25M |
| Gross Profit | $12.008M | $13.09M | $14.46M | $13.69M |
| Gross Profit Ratio | $0.43 | $0.43 | $0.45 | $0.44 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $15.56M | $15.77M | $16.55M | $13.85M |
| Operating Expenses | $15.56M | $38.08M | $17.81M | $14.84M |
| Total Costs & Expenses | $31.59M | $26.61M | $35.48M | $32.23M |
| Interest Income | $0.00 | $0.00 | $30263.00 | $84580.00 |
| Interest Expense | -$176411.00 | $459153.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $3.59M | $3.58M | $3.23M |
| EBITDA | -$6.61M | -$2.52M | $664673.00 | $2.08M |
| EBITDA Ratio | -$0.24 | -$0.08 | $0.02 | $0.07 |
| Operating Income | -$6.61M | -$27.39M | -$3.32M | -$1.15M |
| Operating Income Ratio | -$0.24 | -$0.90 | -$0.10 | -$0.04 |
| Other Income/Expenses (Net) | $4.80M | -$149870.00 | $403914.00 | -$2.87M |
| Income Before Tax | -$1.81M | -$25.13M | -$2.92M | -$4.02M |
| Income Before Tax Ratio | -$0.06 | -$0.83 | -$0.09 | -$0.13 |
| Income Tax Expense | $0.00 | $1.30M | $4.49M | $4.05M |
| Net Income | -$1.81M | -$25.69M | -$7.41M | -$8.07M |
| Net Income Ratio | -$0.06 | -$0.85 | -$0.23 | -$0.26 |
| EPS | -$0.01 | -$0.09 | -$0.02 | -$0.03 |
| Diluted EPS | -$0.01 | -$0.09 | -$0.02 | -$0.03 |
| Weighted Avg Shares Outstanding | $325.26M | $292.17M | $325.16M | $289.18M |
| Weighted Avg Shares Outstanding (Diluted) | $325.26M | $292.17M | $325.16M | $289.18M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan